Table 10 Anticancer potential of pyrazolo[1,5-a]pyrimidine conjugate (29–30)
From: Estrogen alpha receptor antagonists for the treatment of breast cancer: a review
| Compound No. | IC50 = µM |
|---|---|
| MCF-7 Cancer cell line | |
| 29 | 1.79 |
| 30 | 2.16 |
| Doxorubicin | 0.473 µM |
From: Estrogen alpha receptor antagonists for the treatment of breast cancer: a review
| Compound No. | IC50 = µM |
|---|---|
| MCF-7 Cancer cell line | |
| 29 | 1.79 |
| 30 | 2.16 |
| Doxorubicin | 0.473 µM |